With the advent of medical marijuana laws in 37 US states and recreational cannabis legalization in 19 states, the conversation around the efficacy of cannabis for treating anxiety disorders has grown more prevalent. However, the subject remains contentious, particularly in Pennsylvania, where anxiety disorders were only added as a qualifying condition for the Pennsylvania Medical Marijuana (PAMMJ) Program in 2019. While some report relief of anxiety symptoms, others raise concerns regarding the potential for dependency and the exacerbation of anxiety at higher dosages.
According to research, medical marijuana evaluation clinics in California have noted that a considerable percentage of patients use marijuana to relieve anxiety and panic attacks while seeking relaxation. In the context of anxiety disorders, there is an air of ambiguity, as patients claim benefits, yet the long-term consequences for mental health remain a topic of debate.
The risks and benefits of cannabis, especially concerning mental health conditions such as anxiety and depression, are complex. Reports suggest that low doses of THC, the primary psychoactive compound in marijuana, may alleviate stress associated with activities like public speaking. However, it’s not as straightforward as it may seem. At slightly higher doses, THC could increase anxiety, hinting at a dose-dependent relationship that necessitates caution.
Concerns are heightened when considering the use of marijuana in adolescents. There is a consensus in the medical community, as supported by Greater Good, that marijuana use during adolescence may lead to a dysregulated stress response, potentially increasing the risk of developing anxiety disorders later in life. Moreover, cognitive effects have been observed in individuals with long-term cannabis use, as discussed by Harvard Health.
It’s not just younger individuals who are partaking in cannabis use; older adults are increasingly turning to medical marijuana, possibly due to a reduced stigma. Research from the Journal of the American Medical Association indicates a rising trend among those aged 65 and older. Yet, despite this uptick in use, the potential for adverse effects such as addiction, drug interactions, and worsening anxiety at high doses still exists.
Given the potential implications for physical health—such as effects on heart rate and lung function, as highlighted by Harvard Health—the debate around the use of medical marijuana for anxiety relief is far from settled. The medical community appears to be grappling with the duality of marijuana’s therapeutic potential and its possible risks, leaving the topic open for further research and discussion.
